Glucose intolerance in nonischemic cardiac disease. Role of cardiac output and adrenergic function.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002302:Cardiac Output; D009202:Cardiomyopathies / Q000378:metabolism; D002312:Cardiomyopathy, Hypertrophic / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006331:Heart Diseases / Q000378:metabolism* / Q000601:surgery; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D008659:Metabolic Diseases; D008875:Middle Aged; D010494:Pericarditis, Constrictive / Q000378:metabolism; D010643:Phenoxybenzamine; D011433:Propranolol; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D014044:Tolbutamide
D007328:Insulin; D010643:Phenoxybenzamine; D014044:Tolbutamide; D011433:Propranolol; D005947:Glucose